Table 1.
S.No | Studies | Type of study | Glycemic variations and outcomes |
|||
---|---|---|---|---|---|---|
Type of glycemic variation | Decision range/cut-off | Outcomes | ||||
1. | Wang et al. (2020) [30] | Retrospective | Fasting blood glucose (FBG) | FBG ≥ 126 mg/dL | Fasting blood glucose ≥ 126 mg/dL was associated with 28-day mortality risk in COVID-19 patients | |
2. | Li et al. (2020) [27] | Retrospective | Blood glucose within 24 h after ICU admission | Average, minimum, and maximum blood glucose levels within 24 h of hospital admission | Predicted lowest mortality risk and better prognosis for average and maximin blood glucose in the range of 110-140 mg/dL and for minimum blood glucose in the range of 80-110mg/dL within 24 hr after ICU admission | |
3. | Mcgrade et al. (2019) [26] | Retrospective | Elevated blood glucose during hospital admission | Blood glucose levels in quartiles; <55 mg/dL, 55–140 mg/dL,140–200 mg/dL and >200 mg/dL | Highest mortality in quartiles with blood glucose levels <55 mg/dL and >200 mg/dL | |
4. | Lee et al. (2018) [15] | Retrospective | Normal fasting glucose (NFG): Impaired fasting plasma glucose (IFG) | NFG< 100 mg/dL: IFG:100.0–125.9 mg/dL | Increased all-cause mortality in patients when status is shifted from NFG to IFG. | |
Impaired fasting glucose (IFG): Diabetic fasting glucose (DFG) | IFG: 100.0–125.9 mg/dL: DFG≥ 126.0 mg/dL | Increased risk of stroke and all-cause mortality in patients when status is shifted from NFG to DFG | ||||
5. | Ausk et al. (2010) [8] | Prospective | Insulin resistance by homeostasis model assessment | Quartiles of HOMA-IR HOMA-IR < 1.4 HOMA-IR >1.4–2.0 HOMA-IR>2.0–2.8 HOMA-IR>2.8 |
Increased mortality risk in quartile with HOMA-IR>2.8 Increased cardiovascular mortality in quartiles with HOMA-IR >1.4–2.0 HOMA-IR>2.0–2.8 HOMA-IR>2.8 |
|
6. | Barsheshet et al. (2006) [28] | Prospective | Admission blood glucose levels | Admission blood glucose: First tertile: 84–97 mg/dL Second tertile: 108–121 mg/dL Third tertile: 136–162 mg/dL |
Increased in- hospital and 60-day mortality observed in third tertile with admission blood glucose levels are between is 136–162 mg/dL Each 18 mg/dL rise in blood glucose was associated with 31% in-hospital mortality risk and 12% 60-day mortality |
|
7. | Levintan et al. (2004) [17] | Meta-analysis of prospective studies | High post-challenge blood glucose | Post-challenge blood glucose Highest postchallenge glucose midpoint range :150-194 mg/dL Lowest postchallenge glucose midpoint range : 69-107 mg/dL |
Increased risk of CVD in individuals with highest post-challenge blood glucose, midpoint range:150–194 mg/dL compared to individuals with lowest postchallenge glucose midpoint range. | |
8. | Balkau et al. (1998) [6] | Review on Whitehall, Paris Prospective & Helsinki Policeman studies | High but non-diabetic blood glucose levels | 2 h blood glucose and fasting blood glucose | Increased risk of all-cause mortality observed for subjects in upper 20% of 2 h glucose & upper 2.5% of fasting blood in comparison with subjects in the lower 80% of these distributions |